Covid-19

CV. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine

Oberhardt, V., Luxenburger, H., Kemming, J. et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature (2021). https://doi.org/10.1038/s41586-021-03841-4 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 28/07/2021 Abstract SARS-CoV-2 spike mRNA vaccines1–3 mediate protection from severe disease as early as 10 days post prime vaccination3, when neutralizing

CV. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine Leer más »

CV. How the coronavirus infects cells — and why Delta is so dangerous

Scientists are unpicking SARS-CoV-2’s life cycle. By Megan Scudellari. How the coronavirus infects cells — and why Delta is so dangerous (nature.com) Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 28/07/2021 The coronavirus sports a luxurious sugar coat. “It’s striking,” thought Rommie Amaro, staring at her computer

CV. How the coronavirus infects cells — and why Delta is so dangerous Leer más »

CV. Can we clinically identify pre-symptomatic and asymptomatic COVID-19?

Salaheldin Elhamamsy et al. doi: https://doi.org/10.1101/2021.07.23.21260676 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 27/07/2021 Abstract Objectives: COVID-19 has had a severe impact on morbidity and mortality among nursing home (NH) residents. Earlier detection of SARS-CoV-2 may position us to better mitigate risk of spread. Both asymptomatic or pre-symptomatic

CV. Can we clinically identify pre-symptomatic and asymptomatic COVID-19? Leer más »

CV. COVID-19 Seguimiento Venezuela. 24 de julio de 2021 Semana Epidemiológica N°30 Según Data Oficial Dr. Luis Azpurua

De Acuerdo a la Data Oficial: Se observa un dinámica epidémica estable que tiende hacia la baja. La media de crecimiento intersemanal nacional pasa de 2,81% a 2,43%. Crecimiento intersemanal de 7.974 casos. El valor más bajo en las últimas 17 semanas. Pero está a nivel del pico epidémico de julio – octubre 2020. Razón

CV. COVID-19 Seguimiento Venezuela. 24 de julio de 2021 Semana Epidemiológica N°30 Según Data Oficial Dr. Luis Azpurua Leer más »

CV. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Manish Sadarangani, Arnaud Marchant and Tobias R. Kollmann. Nature Reviews | Immunology Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 26/07/2021 Abstract Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including mRNA, adenoviral-vectored, protein subunit

CV. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans Leer más »

CV. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

Ikegame, S., Siddiquey, M.N.A., Hung, CT. et al. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants. Nat Commun 12, 4598 (2021). https://doi.org/10.1038/s41467-021-24909-9 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 26/07/2021 Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identification as

CV. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants Leer más »

CV. Coronavirus disease 2019 vaccines in pregnancy

Amanda M. Craig, et al. DOI:https://doi.org/10.1016/j.ajogmf.2020.100295 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 25/07/2021 As of December 1, 2020, nearly 64 million people have been infected with the severe acute respiratory syndrome coronavirus 2 worldwide with nearly 1.5 million global deaths. The impact of this virus

CV. Coronavirus disease 2019 vaccines in pregnancy Leer más »

CV. Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity to SARS CoV-2 after a Single Dose

Andrés H. Rossi et al. https://doi.org/10.1016/j.xcrm.2021.100359 (https://www.sciencedirect.com/science/article/pii/S2666379121002081) Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 25/07/2021 Summary Massive vaccination offers great promise for halting the global COVID-19 pandemic. However, limited supply and uneven vaccine distribution create an urgent need to optimize vaccination strategies. We evaluate SARS-CoV-2-specific antibody

CV. Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity to SARS CoV-2 after a Single Dose Leer más »

CV. Coronavirus disease 2019 infection and placental histopathology in women delivering at term

Elizabeth T. Patberg, et al. DOI:https://doi.org/10.1016/j.ajog.2020.10.020 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 25/07/2021 Abstract There is a paucity of data describing the effects of coronavirus disease 2019 on placental pathology, especially in asymptomatic patients. Although the pathophysiology of coronavirus disease 2019 is not completely understood,

CV. Coronavirus disease 2019 infection and placental histopathology in women delivering at term Leer más »